PCSK9 Inhibitor [EPC]

PCSK9 Inhibitor [EPC] was reported 25752 times

Drugs of the PCSK9 Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 FRACTIONAL EXHALED NITRIC OXIDE INCREASED 128 0.7151
1 LOW DENSITY LIPOPROTEIN DECREASED 851 0.6006
2 INCORRECT DISPOSAL OF PRODUCT 1746 0.5371
3 DEVICE DIFFICULT TO USE 33307 0.5027
4 SKIN PRESSURE MARK 86 0.4057
5 LOW DENSITY LIPOPROTEIN ABNORMAL 235 0.3834
6 PRODUCT COMMUNICATION ISSUE 2939 0.3328
7 TYPE IIA HYPERLIPIDAEMIA 77 0.3291
8 INTERCEPTED PRODUCT ADMINISTRATION ERROR 2523 0.3287
9 DRUG DOSE OMISSION BY DEVICE 25089 0.3201
10 BLOOD CHOLESTEROL DECREASED 546 0.2929
11 COMPUTERISED TOMOGRAM HEART ABNORMAL 23 0.2805
12 PRODUCT KNOWLEDGE DEFICIT 205 0.2621
13 LIPOPROTEIN (A) INCREASED 85 0.2599
14 INJECTION SITE INDENTATION 463 0.2136
15 LOW DENSITY LIPOPROTEIN INCREASED 1540 0.1987
16 LACK OF ADMINISTRATION SITE ROTATION 55 0.1803
17 ACCIDENTAL EXPOSURE TO PRODUCT 17230 0.1670
18 PRODUCT PREPARATION ERROR 3226 0.1569
19 OCCUPATIONAL EXPOSURE TO PRODUCT 960 0.1492
20 DEVICE USE ERROR 4435 0.1275
21 HIGH DENSITY LIPOPROTEIN ABNORMAL 29 0.1234
22 INCORRECT DOSE ADMINISTERED BY DEVICE 3204 0.1221
23 LACK OF INJECTION SITE ROTATION 205 0.1171
24 PRODUCT DELIVERY MECHANISM ISSUE 612 0.1137
25 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 22769 0.1122
26 VASCULAR STENT STENOSIS 47 0.1116
27 INCORRECT DOSE ADMINISTERED BY PRODUCT 173 0.1081
28 RUBBER SENSITIVITY 158 0.1031
29 OBSTRUCTIVE SLEEP APNOEA SYNDROME 146 0.1001
30 DEVICE DISPENSING ERROR 117 0.0991
31 APPLICATION SITE MASS 27 0.0985
32 FEAR OF INJECTION 658 0.0921
33 INJURY ASSOCIATED WITH DEVICE 1874 0.0919
34 HIGH DENSITY LIPOPROTEIN INCREASED 88 0.0884
35 MYOGLOBIN BLOOD INCREASED 134 0.0876
36 BLOOD TRIGLYCERIDES DECREASED 29 0.0861
37 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 2882 0.0852
38 PRODUCT STORAGE ERROR 7071 0.0807
39 INJECTION SITE BRUISING 5820 0.0729
40 RHINORRHOEA 4187 0.0647
41 BLOOD TRIGLYCERIDES ABNORMAL 54 0.0616
42 INJECTION SITE HYPOAESTHESIA 88 0.0615
43 INJECTION SITE HAEMORRHAGE 4864 0.0608
44 LIPIDS ABNORMAL 42 0.0580
45 STENT PLACEMENT 464 0.0575
46 INJECTION SITE DISCOMFORT 585 0.0556
47 INJECTION SITE DISCOLOURATION 674 0.0539
48 BLOOD CHOLESTEROL ABNORMAL 247 0.0534
49 HIGH DENSITY LIPOPROTEIN DECREASED 175 0.0525
50 PLANTAR FASCIITIS 166 0.0494
51 INFLUENZA LIKE ILLNESS 3989 0.0484
52 INJECTION SITE MASS 1669 0.0451
53 CARDIAC OPERATION 386 0.0449
54 BRAIN NATRIURETIC PEPTIDE INCREASED 137 0.0444
55 PRODUCT PREPARATION ISSUE 290 0.0442
56 VASCULAR GRAFT 127 0.0440
57 INJECTION SITE PARAESTHESIA 66 0.0430
58 BLOOD TRIGLYCERIDES INCREASED 753 0.0426
59 MYALGIA 7078 0.0416
60 INJECTION SITE VESICLES 250 0.0413
61 INJECTION SITE PAIN 12599 0.0410
62 WRONG SCHEDULE 39 0.0409
63 INJECTION SITE LACERATION 26 0.0406
64 AORTIC VALVE REPLACEMENT 50 0.0399
65 LIPIDS INCREASED 80 0.0396
66 CORONARY ARTERY BYPASS 223 0.0387
67 INTERCEPTED PRODUCT STORAGE ERROR 137 0.0384
68 PARANASAL SINUS HYPERSECRETION 141 0.0369
69 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 658 0.0359
70 CORONARY ARTERIAL STENT INSERTION 180 0.0355
71 BLOOD CHOLESTEROL INCREASED 1648 0.0353
72 PRODUCT ADMINISTRATION ERROR 713 0.0352
73 CATHETERISATION CARDIAC 153 0.0345
74 MUSCLE DISCOMFORT 27 0.0344
75 MUSCLE DISORDER 278 0.0343
76 VASCULAR OCCLUSION 72 0.0341
77 INJECTION SITE SWELLING 2582 0.0337
78 DEVICE OPERATIONAL ISSUE 143 0.0332
79 INJECTION SITE SCAB 32 0.0332
80 CAROTID ARTERIOSCLEROSIS 33 0.0320
81 DRUG DOSE OMISSION 5254 0.0318
82 EXPOSURE VIA SKIN CONTACT 820 0.0316
83 DEVICE USE ISSUE 545 0.0311
84 HEART VALVE REPLACEMENT 46 0.0311
85 INJECTION SITE INJURY 172 0.0310
86 PRODUCT DOSE OMISSION 2009 0.0307
87 SUBCLAVIAN VEIN THROMBOSIS 35 0.0307
88 ADVERSE REACTION 397 0.0299
89 UPPER-AIRWAY COUGH SYNDROME 234 0.0284
90 INJECTION SITE HYPERSENSITIVITY 88 0.0281
91 DEVICE ISSUE 2472 0.0275
92 PERIPHERAL ARTERY OCCLUSION 38 0.0270
93 BACK PAIN 6128 0.0264
94 INJECTION SITE URTICARIA 647 0.0263
95 INJECTION SITE RASH 797 0.0260
96 INJECTION SITE INDURATION 323 0.0249
97 MEDICAL DEVICE IMPLANTATION 39 0.0248
98 SINUS DISORDER 489 0.0247
99 DEVICE DEFECTIVE 425 0.0245
100 INJECTION SITE EXTRAVASATION 300 0.0243
101 WAIST CIRCUMFERENCE INCREASED 25 0.0241
102 MUSCLE FATIGUE 101 0.0238
103 MUSCLE SPASMS 4374 0.0238
104 INJECTION RELATED REACTION 39 0.0236
105 GLYCOSYLATED HAEMOGLOBIN DECREASED 38 0.0236
106 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 1057 0.0226
107 UNDERDOSE 1631 0.0223
108 INJECTION SITE ERYTHEMA 2686 0.0216
109 INJECTION SITE PRURITUS 1442 0.0215
110 SECRETION DISCHARGE 268 0.0214
111 HYPOACUSIS 903 0.0210
112 ESSENTIAL HYPERTENSION 38 0.0207
113 CAROTID ARTERY OCCLUSION 75 0.0205
114 CORONARY ARTERY OCCLUSION 281 0.0205
115 GLYCOSYLATED HAEMOGLOBIN INCREASED 516 0.0204
116 CAROTID ARTERY DISEASE 26 0.0204
117 IMPLANTABLE DEFIBRILLATOR INSERTION 27 0.0204
118 EAR CONGESTION 54 0.0199
119 COLONOSCOPY 43 0.0195
120 OROPHARYNGEAL PAIN 1806 0.0195
121 ARTERIAL OCCLUSIVE DISEASE 153 0.0194
122 SENSATION OF FOREIGN BODY 163 0.0193
123 INJECTION SITE SCAR 54 0.0189
124 SINUS PAIN 44 0.0189
125 NASAL DISORDER 50 0.0188
126 ANGINA UNSTABLE 121 0.0186
127 SNEEZING 412 0.0184
128 EYE OPERATION 84 0.0182
129 ANGIOPLASTY 27 0.0181
130 INJECTION SITE INFLAMMATION 90 0.0180
131 MUSCULOSKELETAL PAIN 946 0.0180
132 ARTERIAL DISORDER 33 0.0173
133 MIDDLE EAR EFFUSION 38 0.0172
134 UNEVALUABLE EVENT 1298 0.0171
135 INCREASED UPPER AIRWAY SECRETION 88 0.0171
136 RESPIRATORY TRACT CONGESTION 270 0.0170
137 MUSCULOSKELETAL DISORDER 322 0.0169
138 NASOPHARYNGITIS 3109 0.0168
139 APPLICATION SITE HAEMORRHAGE 46 0.0168
140 SPINAL OPERATION 203 0.0165
141 ARTERIOSCLEROSIS 154 0.0163
142 RESPIRATORY SYMPTOM 46 0.0162
143 MUSCULOSKELETAL DISCOMFORT 273 0.0158
144 BLOOD CREATINE PHOSPHOKINASE INCREASED 456 0.0158
145 INJECTION SITE WARMTH 325 0.0158
146 CARDIAC ABLATION 28 0.0157
147 CARDIAC PACEMAKER INSERTION 93 0.0156
148 INCREASED TENDENCY TO BRUISE 143 0.0155
149 GLUCOSE TOLERANCE IMPAIRED 91 0.0154
150 EXOSTOSIS 140 0.0153
151 SINUS CONGESTION 207 0.0153
152 NASAL CONGESTION 896 0.0152
153 INJECTION SITE IRRITATION 194 0.0152
154 PAIN IN EXTREMITY 4478 0.0152
155 INDURATION 27 0.0151
156 CATHETER PLACEMENT 28 0.0151
157 PRODUCT SUPPLY ISSUE 107 0.0150
158 PRODUCT TEMPERATURE EXCURSION ISSUE 77 0.0150
159 THROAT CLEARING 56 0.0149
160 CAROTID ARTERY STENOSIS 52 0.0149
161 SHOULDER ARTHROPLASTY 40 0.0148
162 BACK DISORDER 241 0.0148
163 POLYMYALGIA RHEUMATICA 47 0.0148
164 THERAPY INTERRUPTED 1056 0.0148
165 MUSCLE TIGHTNESS 239 0.0147
166 VIRAL UPPER RESPIRATORY TRACT INFECTION 70 0.0147
167 PRURITUS GENERALISED 313 0.0145
168 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 245 0.0144
169 CORONARY ARTERY STENOSIS 72 0.0143
170 THERAPY NON-RESPONDER 643 0.0143
171 SPINAL STENOSIS 59 0.0143
172 NECK SURGERY 33 0.0142
173 PARANASAL SINUS DISCOMFORT 53 0.0140
174 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 57 0.0139
175 ANGINA PECTORIS 384 0.0134
176 RHINITIS 108 0.0134
177 INCORRECT DRUG ADMINISTRATION RATE 57 0.0134
178 INFLUENZA 1491 0.0134
179 STENOSIS 25 0.0133
180 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 86 0.0132
181 AORTIC STENOSIS 46 0.0132
182 DYSPHONIA 771 0.0132
183 LIMB OPERATION 63 0.0131
184 MUSCULAR WEAKNESS 1484 0.0130
185 INJECTION SITE REACTION 897 0.0130
186 JOINT LOCK 37 0.0130
187 RASH PRURITIC 698 0.0129
188 GROIN PAIN 113 0.0129
189 LIMB DISCOMFORT 397 0.0128
190 DRY THROAT 130 0.0128
191 TRIGGER FINGER 52 0.0127
192 OBSTRUCTIVE AIRWAYS DISORDER 141 0.0127
193 BRAIN FOG 197 0.0126
194 DEVICE FAILURE 190 0.0125
195 ARTHRALGIA 5162 0.0124
196 NECK PAIN 693 0.0124
197 OROPHARYNGEAL DISCOMFORT 111 0.0123
198 MOBILITY DECREASED 881 0.0122
199 ARTERIOSCLEROSIS CORONARY ARTERY 81 0.0122
200 THERAPEUTIC RESPONSE UNEXPECTED 546 0.0122
201 SHOULDER OPERATION 52 0.0122
202 PHARYNGEAL SWELLING 119 0.0122
203 DRUG EFFECT LESS THAN EXPECTED 178 0.0120
204 KNEE OPERATION 118 0.0120
205 PRODUCT DISPENSING ERROR 258 0.0118
206 LABORATORY TEST ABNORMAL 349 0.0118
207 SINUS HEADACHE 70 0.0118
208 HEAD DISCOMFORT 206 0.0116
209 MUSCLE RUPTURE 45 0.0115
210 CORONARY ARTERY DISEASE 344 0.0113
211 DRUG DELIVERY SYSTEM MALFUNCTION 58 0.0113
212 INTENTIONAL PRODUCT MISUSE 988 0.0113
213 INJECTION SITE DISCHARGE 60 0.0111
214 REHABILITATION THERAPY 43 0.0111
215 UPPER RESPIRATORY TRACT CONGESTION 32 0.0110
216 MEMORY IMPAIRMENT 1506 0.0110
217 LIMB MASS 24 0.0109
218 SLUGGISHNESS 111 0.0109
219 APHONIA 151 0.0108
220 FOREIGN BODY IN THROAT 34 0.0108
221 PAPULE 76 0.0108
222 HERNIA REPAIR 28 0.0108
223 DISABILITY 213 0.0108
224 PRODUCT DISPENSING ISSUE 46 0.0107
225 PRODUCT ADMINISTRATION INTERRUPTED 84 0.0107
226 BLOOD GLUCOSE INCREASED 2014 0.0107
227 DRUG EFFECT INCOMPLETE 388 0.0107
228 RASH VESICULAR 51 0.0105
229 MULTIPLE USE OF SINGLE-USE PRODUCT 59 0.0105
230 KNEE ARTHROPLASTY 221 0.0105
231 COUGH 2930 0.0104
232 HIP ARTHROPLASTY 160 0.0104
233 BLADDER PAIN 33 0.0104
234 URINE ODOUR ABNORMAL 61 0.0104
235 ANGIOPATHY 58 0.0103
236 ARTHRITIS 811 0.0103
237 SCIATICA 164 0.0103
238 ADVERSE EVENT 947 0.0103
239 APPLICATION SITE SWELLING 51 0.0102
240 CARDIAC FLUTTER 66 0.0102
241 INJECTION SITE HAEMATOMA 148 0.0102
242 SEASONAL ALLERGY 144 0.0102
243 SKIN ODOUR ABNORMAL 40 0.0102
244 DIABETES MELLITUS 774 0.0101
245 VARICOSE VEIN 52 0.0101
246 MUSCLE STRAIN 87 0.0100
247 DEMENTIA 281 0.0100
248 ANEURYSM 50 0.0100
249 CONTUSION 965 0.0100
250 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 171 0.0100
251 BONE PAIN 582 0.0099
252 TONGUE DISCOMFORT 42 0.0099
253 ILL-DEFINED DISORDER 594 0.0098
254 PHARYNGEAL DISORDER 28 0.0097
255 MACULAR DEGENERATION 116 0.0097
256 UPPER RESPIRATORY TRACT INFECTION 448 0.0097
257 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1747 0.0097
258 LIPOMA 25 0.0096
259 BLOOD PRESSURE ABNORMAL 191 0.0096
260 ARTHROPOD BITE 71 0.0096
261 MUSCLE ATROPHY 121 0.0095
262 EAR DISCOMFORT 98 0.0095
263 BLOOD GLUCOSE ABNORMAL 176 0.0095
264 MYOCARDIAL INFARCTION 1653 0.0095
265 GOUT 170 0.0095
266 CATARACT OPERATION 56 0.0094
267 DEVICE MALFUNCTION 661 0.0094
268 EAR DISORDER 43 0.0094
269 MYOPATHY 81 0.0094
270 HEPATIC PAIN 40 0.0094
271 EAR PAIN 181 0.0093
272 MENISCUS INJURY 57 0.0093
273 SURGERY 543 0.0093
274 CHEMOTHERAPY 35 0.0092
275 JOINT STIFFNESS 242 0.0092
276 GALLBLADDER OPERATION 37 0.0091
277 EXFOLIATIVE RASH 24 0.0091
278 AUTOIMMUNE DISORDER 88 0.0090
279 RASH GENERALISED 233 0.0090
280 TENDON PAIN 68 0.0090
281 MUSCULOSKELETAL CHEST PAIN 139 0.0090
282 THROAT IRRITATION 402 0.0090
283 FEELING ABNORMAL 2142 0.0089
284 CARDIAC DISORDER 836 0.0089
285 MIGRAINE WITH AURA 24 0.0088
286 INTENTIONAL DOSE OMISSION 250 0.0088
287 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 619 0.0087
288 PARAESTHESIA ORAL 125 0.0087
289 SPINAL FUSION SURGERY 35 0.0086
290 SINUSITIS 878 0.0086
291 GASTROINTESTINAL PAIN 94 0.0085
292 CHEST DISCOMFORT 860 0.0084
293 BOWEL MOVEMENT IRREGULARITY 64 0.0083
294 HIP SURGERY 45 0.0083
295 GAIT INABILITY 277 0.0083
296 EMBOLISM VENOUS 25 0.0082
297 MUSCULOSKELETAL STIFFNESS 721 0.0082
298 PULMONARY PAIN 24 0.0082
299 THERAPY CESSATION 420 0.0082
300 PERIPHERAL VASCULAR DISORDER 42 0.0081
301 LIVER FUNCTION TEST INCREASED 175 0.0081
302 DYSPNOEA EXERTIONAL 307 0.0081
303 HAEMORRHAGIC DIATHESIS 29 0.0081
304 PRODUCT DOSE OMISSION ISSUE 2379 0.0081
305 FIBROMYALGIA 196 0.0081
306 BRONCHITIS 596 0.0080
307 NERVE COMPRESSION 74 0.0080
308 BLOOD BLISTER 25 0.0080
309 AMNESIA 518 0.0080
310 GAIT DISTURBANCE 1515 0.0079
311 PANCREATIC DISORDER 39 0.0079
312 CEREBRAL DISORDER 58 0.0078
313 NECK INJURY 23 0.0078
314 PNEUMOTHORAX 124 0.0078
315 EXERCISE TOLERANCE DECREASED 45 0.0078
316 ABNORMAL FAECES 64 0.0078
317 MYOSITIS 70 0.0078
318 LACRIMATION INCREASED 235 0.0078
319 LIP SWELLING 259 0.0078
320 TRANSIENT ISCHAEMIC ATTACK 262 0.0078
321 EOSINOPHILIA 136 0.0078
322 RENAL TRANSPLANT 28 0.0077
323 SWOLLEN TONGUE 242 0.0077
324 HEART RATE ABNORMAL 43 0.0077
325 NASAL DRYNESS 48 0.0077
326 INJECTION SITE PAPULE 35 0.0076
327 PERIPHERAL SWELLING 1178 0.0076
328 RENAL PAIN 81 0.0076
329 SKIN MASS 51 0.0076
330 PROSTATOMEGALY 30 0.0076
331 HYPERCHOLESTEROLAEMIA 73 0.0076
332 SKIN HAEMORRHAGE 112 0.0075
333 SWELLING FACE 488 0.0075
334 CEREBROVASCULAR ACCIDENT 1266 0.0075
335 VENTRICULAR HYPOKINESIA 24 0.0075
336 INTRACRANIAL ANEURYSM 30 0.0075
337 THROAT TIGHTNESS 202 0.0075
338 PRODUCTIVE COUGH 355 0.0074
339 SPONDYLITIS 27 0.0074
340 EYE DISORDER 244 0.0074
341 NEEDLE ISSUE 216 0.0074
342 HEPATIC ENZYME ABNORMAL 37 0.0074
343 ADVERSE DRUG REACTION 665 0.0074
344 DYSSTASIA 216 0.0074
345 VEIN DISORDER 37 0.0074
346 CHEST PAIN 1369 0.0074
347 PRODUCT LABEL CONFUSION 43 0.0074
348 INTERCEPTED MEDICATION ERROR 34 0.0073
349 BURNING SENSATION 514 0.0073
350 DEVICE PHYSICAL PROPERTY ISSUE 56 0.0073
351 URINE ABNORMALITY 33 0.0073
352 HYPERSENSITIVITY 1347 0.0072
353 DIVERTICULITIS 201 0.0072
354 URTICARIA 1213 0.0072
355 AORTIC ANEURYSM 55 0.0072
356 NERVOUSNESS 375 0.0072
357 BLOOD PRESSURE INCREASED 1096 0.0072
358 ARTHROPATHY 398 0.0072
359 PULMONARY CONGESTION 94 0.0071
360 NEURALGIA 173 0.0071
361 FOOT OPERATION 35 0.0071
362 FRUSTRATION TOLERANCE DECREASED 57 0.0070
363 TENDONITIS 108 0.0070
364 RASH PAPULAR 156 0.0070
365 NASAL DISCOMFORT 55 0.0069
366 MOUTH SWELLING 40 0.0069
367 LYME DISEASE 23 0.0069
368 OVERWEIGHT 37 0.0069
369 VISUAL IMPAIRMENT 846 0.0068
370 TENDERNESS 71 0.0068
371 THYROID MASS 26 0.0068
372 PHARYNGEAL OEDEMA 104 0.0068
373 INJECTION SITE NODULE 74 0.0067
374 FACIAL PAIN 60 0.0067
375 PAIN 4124 0.0067
376 LIMB INJURY 182 0.0067
377 LETHARGY 382 0.0066
378 FATIGUE 5164 0.0066
379 BLOOD TEST ABNORMAL 93 0.0066
380 PAIN IN JAW 186 0.0066
381 INTERVERTEBRAL DISC DISORDER 28 0.0066
382 PERIORBITAL SWELLING 37 0.0065
383 ONYCHOCLASIS 45 0.0065
384 ACUTE CORONARY SYNDROME 54 0.0065
385 TOOTHACHE 118 0.0065
386 CATARACT 385 0.0065
387 ILLNESS 666 0.0065
388 RENAL FUNCTION TEST ABNORMAL 30 0.0065
389 RESPIRATORY DISORDER 193 0.0064
390 POLLAKIURIA 269 0.0064
391 FEELING COLD 179 0.0064
392 RASH ERYTHEMATOUS 307 0.0064
393 GUILLAIN-BARRE SYNDROME 31 0.0064
394 DIZZINESS POSTURAL 62 0.0064
395 DIZZINESS 3188 0.0064
396 MASS 89 0.0064
397 SCRATCH 67 0.0063
398 CHOKING SENSATION 35 0.0063
399 SKIN LACERATION 69 0.0063
400 PROSTATIC DISORDER 35 0.0063
401 TINNITUS 291 0.0063
402 CARDIAC VALVE DISEASE 36 0.0063
403 TENDON DISORDER 41 0.0063
404 HOSPITALISATION 965 0.0063
405 BLOOD CALCIUM INCREASED 55 0.0063
406 RASH MACULAR 219 0.0063
407 HEADACHE 3915 0.0062
408 PRURITUS 2397 0.0062
409 VERTIGO 380 0.0062
410 CHAPPED LIPS 27 0.0062
411 BLOOD GLUCOSE FLUCTUATION 68 0.0062
412 CORONAVIRUS INFECTION 41 0.0062
413 CONCUSSION 48 0.0062
414 FLANK PAIN 58 0.0062
415 CHOLECYSTECTOMY 70 0.0061
416 CHROMATURIA 138 0.0061
417 ACUTE MYOCARDIAL INFARCTION 180 0.0061
418 HYPOAESTHESIA ORAL 92 0.0061
419 ROTATOR CUFF SYNDROME 78 0.0061
420 HEPATIC ENZYME INCREASED 414 0.0061
421 ASTHENIA 2282 0.0061
422 PRESYNCOPE 147 0.0060
423 MUSCLE INJURY 50 0.0060
424 RASH 2629 0.0060
425 SPINAL DISORDER 57 0.0060
426 FLATULENCE 341 0.0060
427 ATRIAL FIBRILLATION 584 0.0060
428 TENDON RUPTURE 74 0.0060
429 INFARCTION 41 0.0060
430 RESPIRATION ABNORMAL 41 0.0059
431 COLITIS MICROSCOPIC 28 0.0059
432 MALAISE 2588 0.0059
433 PHARYNGITIS 73 0.0059
434 ABDOMINAL DISCOMFORT 986 0.0059
435 HEPATIC STEATOSIS 109 0.0058
436 IMMUNE SYSTEM DISORDER 77 0.0058
437 DEAFNESS 152 0.0058
438 OCULAR DISCOMFORT 65 0.0058
439 DIALYSIS 82 0.0058
440 URINARY TRACT DISORDER 26 0.0058
441 FEELING HOT 352 0.0057
442 ABDOMINAL PAIN UPPER 1182 0.0057
443 WHEEZING 338 0.0057
444 WEIGHT INCREASED 1271 0.0057
445 SPINAL PAIN 66 0.0056
446 COGNITIVE DISORDER 263 0.0056
447 HYPOAESTHESIA 839 0.0056
448 BURSITIS 68 0.0056
449 WRIST FRACTURE 67 0.0056
450 DRY MOUTH 450 0.0055
451 PERIPHERAL COLDNESS 76 0.0055
452 RENAL DISORDER 257 0.0055
453 DYSLIPIDAEMIA 28 0.0055
454 CHILLS 645 0.0055
455 NEUROPATHY PERIPHERAL 523 0.0055
456 INTERVERTEBRAL DISC PROTRUSION 120 0.0055
457 AUTOIMMUNE HEPATITIS 38 0.0055
458 THYROID DISORDER 84 0.0054
459 COLD SWEAT 96 0.0054
460 EXTRASYSTOLES 38 0.0054
461 URINARY TRACT INFECTION 926 0.0054
462 SWELLING 508 0.0054
463 BLOOD TESTOSTERONE DECREASED 37 0.0054
464 DISCOMFORT 330 0.0054
465 SKIN ATROPHY 31 0.0054
466 SPUTUM DISCOLOURED 51 0.0054
467 BLOOD URINE PRESENT 102 0.0054
468 ACCIDENT 64 0.0054
469 SLEEP DISORDER 378 0.0054
470 SKIN DISCOLOURATION 246 0.0053
471 GRIP STRENGTH DECREASED 47 0.0053
472 JOINT INJURY 114 0.0053
473 IRRITABLE BOWEL SYNDROME 114 0.0053
474 DIARRHOEA 3413 0.0053
475 IMMOBILE 23 0.0053
476 DEAFNESS UNILATERAL 29 0.0053
477 DERMATITIS CONTACT 60 0.0053
478 BACK INJURY 57 0.0052
479 DYSPNOEA 2959 0.0052
480 PARAESTHESIA 820 0.0052
481 GASTROENTERITIS 76 0.0052
482 CARDIOVASCULAR DISORDER 132 0.0052
483 ABDOMINAL DISTENSION 542 0.0052
484 EYE SWELLING 193 0.0052
485 FOOD ALLERGY 40 0.0052
486 PAROSMIA 39 0.0052
487 KIDNEY INFECTION 101 0.0051
488 FOOD CRAVING 27 0.0051
489 GASTRIC DISORDER 176 0.0051
490 PRODUCT PRESCRIBING ERROR 122 0.0051
491 HERPES ZOSTER 294 0.0051
492 ERUCTATION 99 0.0051
493 TONGUE DISORDER 37 0.0051
494 RESPIRATORY TRACT INFECTION 133 0.0051
495 MULTIPLE ALLERGIES 40 0.0051
496 THERAPEUTIC PRODUCT EFFECT DECREASED 228 0.0051
497 WEIGHT LOSS POOR 26 0.0051
498 MYASTHENIA GRAVIS 41 0.0051
499 HYPERTENSION 1073 0.0051
500 NEOPLASM MALIGNANT 338 0.0051
501 DIABETIC NEUROPATHY 25 0.0050
502 FOOD POISONING 27 0.0050
503 BLOOD URIC ACID INCREASED 29 0.0050
504 RESTLESS LEGS SYNDROME 91 0.0050
505 PANCREATITIS 264 0.0050
506 CHEILITIS 27 0.0050
507 GASTROENTERITIS VIRAL 90 0.0050
508 INCORRECT DOSE ADMINISTERED 1134 0.0050
509 NIGHT SWEATS 160 0.0050
510 CYSTITIS 158 0.0050
511 FAECES SOFT 36 0.0049
512 FEELING OF BODY TEMPERATURE CHANGE 29 0.0049
513 NERVE INJURY 55 0.0049
514 BEDRIDDEN 65 0.0049
515 PALPITATIONS 578 0.0049
516 BLADDER DISORDER 49 0.0049
517 BLEPHAROSPASM 31 0.0049
518 OFF LABEL USE 4303 0.0049
519 SCAB 56 0.0049
520 SKIN TIGHTNESS 23 0.0049
521 HYPERAESTHESIA 40 0.0049
522 GASTROINTESTINAL DISORDER 436 0.0049
523 SKIN SWELLING 42 0.0048
524 HEART RATE IRREGULAR 109 0.0048
525 LIQUID PRODUCT PHYSICAL ISSUE 35 0.0048
526 THINKING ABNORMAL 89 0.0048
527 HYPOKINESIA 69 0.0047
528 ENERGY INCREASED 28 0.0047
529 BLOOD POTASSIUM INCREASED 77 0.0047
530 TOE AMPUTATION 24 0.0047
531 HYPERHIDROSIS 608 0.0047
532 EAR INFECTION 125 0.0047
533 SKIN REACTION 66 0.0047
534 BALANCE DISORDER 404 0.0047
535 ANAL INCONTINENCE 42 0.0047
536 BLOOD GLUCOSE DECREASED 224 0.0047
537 THIRST 83 0.0046
538 APHTHOUS ULCER 36 0.0046
539 CARPAL TUNNEL SYNDROME 65 0.0046
540 JOINT SWELLING 559 0.0046
541 VENTRICULAR EXTRASYSTOLES 48 0.0046
542 UPPER LIMB FRACTURE 92 0.0046
543 HUNGER 64 0.0046
544 POST PROCEDURAL COMPLICATION 88 0.0046
545 GLOMERULAR FILTRATION RATE DECREASED 56 0.0046
546 DRUG INTOLERANCE 440 0.0046
547 LYMPHADENOPATHY 161 0.0045
548 FURUNCLE 36 0.0045
549 GALLBLADDER DISORDER 81 0.0045
550 HYPERSOMNIA 130 0.0045
551 NEPHROLITHIASIS 208 0.0045
552 COVID-19 795 0.0045
553 HYPERLIPIDAEMIA 54 0.0045
554 HIP FRACTURE 145 0.0045
555 SLEEP APNOEA SYNDROME 86 0.0045
556 BREAST PAIN 48 0.0045
557 INCREASED APPETITE 86 0.0045
558 BRONCHOSPASM 64 0.0045
559 HOT FLUSH 337 0.0045
560 SWELLING OF EYELID 28 0.0045
561 FACIAL PARALYSIS 38 0.0045
562 WEIGHT DECREASED 1243 0.0044
563 DRY EYE 222 0.0044
564 VIRAL INFECTION 148 0.0044
565 TOOTH FRACTURE 49 0.0044
566 POST PROCEDURAL INFECTION 36 0.0044
567 MUSCLE TWITCHING 102 0.0044
568 THERAPEUTIC RESPONSE DECREASED 268 0.0044
569 GLAUCOMA 85 0.0044
570 INSURANCE ISSUE 67 0.0044
571 APPETITE DISORDER 29 0.0044
572 MENTAL IMPAIRMENT 106 0.0044
573 LOWER LIMB FRACTURE 84 0.0044
574 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 210 0.0044
575 DRUG ADMINISTERED AT INAPPROPRIATE SITE 46 0.0044
576 LIGAMENT SPRAIN 43 0.0043
577 ALOPECIA 854 0.0043
578 DYSURIA 160 0.0043
579 PHARYNGITIS STREPTOCOCCAL 47 0.0043
580 INCORRECT PRODUCT STORAGE 57 0.0043
581 EPISTAXIS 324 0.0043
582 SKIN WARM 25 0.0043
583 MIGRAINE 409 0.0043
584 EYE PRURITUS 143 0.0043
585 BLOOD PRESSURE FLUCTUATION 102 0.0042
586 ERECTILE DYSFUNCTION 109 0.0042
587 IMPAIRED DRIVING ABILITY 48 0.0042
588 GASTRITIS 111 0.0042
589 GASTROINTESTINAL INFLAMMATION 33 0.0042
590 FEELING JITTERY 80 0.0042
591 HERNIA 81 0.0042
592 FORMICATION 29 0.0042
593 REFUSAL OF TREATMENT BY PATIENT 27 0.0041
594 MYOCARDIAL ISCHAEMIA 47 0.0041
595 VISION BLURRED 564 0.0041
596 GASTROOESOPHAGEAL REFLUX DISEASE 330 0.0041
597 QUALITY OF LIFE DECREASED 55 0.0041
598 TOOTH EXTRACTION 51 0.0041
599 SPINAL OSTEOARTHRITIS 36 0.0041
600 SPINAL FRACTURE 82 0.0041
601 ORAL DISORDER 30 0.0041
602 TASTE DISORDER 83 0.0041
603 ROAD TRAFFIC ACCIDENT 171 0.0041
604 NAUSEA 3222 0.0041
605 VITREOUS FLOATERS 40 0.0041
606 FALL 1353 0.0041
607 FAECES DISCOLOURED 88 0.0041
608 EYE PAIN 229 0.0041
609 DYSPEPSIA 399 0.0041
610 ARRHYTHMIA 192 0.0041
611 HEAD INJURY 128 0.0040
612 EXTRA DOSE ADMINISTERED 163 0.0040
613 IMPAIRED WORK ABILITY 86 0.0040
614 ANKLE FRACTURE 62 0.0040
615 BLOOD PRESSURE SYSTOLIC INCREASED 78 0.0040
616 INTERVERTEBRAL DISC DEGENERATION 37 0.0040
617 CHOKING 78 0.0040
618 DYSGEUSIA 297 0.0040
619 BRAIN INJURY 40 0.0040
620 EYE HAEMORRHAGE 53 0.0040
621 HEART RATE INCREASED 393 0.0040
622 ERYTHEMA 815 0.0040
623 FREQUENT BOWEL MOVEMENTS 107 0.0040
624 ORAL DISCOMFORT 55 0.0040
625 VASCULITIS 46 0.0039
626 POOR QUALITY SLEEP 85 0.0039
627 MICTURITION URGENCY 45 0.0039
628 INTERNAL HAEMORRHAGE 45 0.0039
629 SARS-COV-2 TEST POSITIVE 52 0.0039
630 PROSTATIC SPECIFIC ANTIGEN INCREASED 54 0.0039
631 PARALYSIS 56 0.0039
632 DYSPHAGIA 370 0.0039
633 BONE DISORDER 71 0.0039
634 MITRAL VALVE INCOMPETENCE 44 0.0039
635 PIGMENTATION DISORDER 24 0.0039
636 BLISTER 218 0.0039
637 ATRIOVENTRICULAR BLOCK 30 0.0039
638 APPLICATION SITE PAIN 85 0.0039
639 CHOLELITHIASIS 126 0.0038
640 TYPE 1 DIABETES MELLITUS 23 0.0038
641 DERMATITIS ALLERGIC 48 0.0038
642 INSOMNIA 1015 0.0038
643 POOR QUALITY PRODUCT ADMINISTERED 40 0.0038
644 DRUG DISPENSING ERROR 58 0.0038
645 DISTURBANCE IN ATTENTION 203 0.0038
646 LYMPHOEDEMA 26 0.0038
647 MIDDLE INSOMNIA 70 0.0037
648 HOSPICE CARE 37 0.0037
649 BLOOD DISORDER 30 0.0037
650 VITAMIN D DECREASED 32 0.0037
651 ORAL HERPES 73 0.0037
652 FLUID RETENTION 190 0.0037
653 BLINDNESS 151 0.0037
654 POOR QUALITY DEVICE USED 37 0.0037
655 DECREASED IMMUNE RESPONSIVENESS 36 0.0037
656 SKIN DISORDER 122 0.0037
657 NAIL DISORDER 32 0.0037
658 WEIGHT FLUCTUATION 38 0.0036
659 LOCALISED INFECTION 87 0.0036
660 IMPAIRED GASTRIC EMPTYING 49 0.0036
661 TYPE 2 DIABETES MELLITUS 121 0.0036
662 BLOOD MAGNESIUM DECREASED 31 0.0036
663 VITAMIN D DEFICIENCY 35 0.0036
664 TEMPERATURE INTOLERANCE 37 0.0036
665 CONFUSIONAL STATE 579 0.0036
666 HAEMATOMA 92 0.0035
667 TOOTH ABSCESS 36 0.0035
668 GINGIVAL PAIN 28 0.0035
669 ATRIAL FLUTTER 28 0.0035
670 INFLAMMATION 181 0.0035
671 TOOTH INFECTION 46 0.0035
672 JOINT EFFUSION 24 0.0035
673 BLOOD THYROID STIMULATING HORMONE INCREASED 32 0.0035
674 TREMOR 577 0.0035
675 HYSTERECTOMY 30 0.0035
676 TOOTH DISORDER 77 0.0035
677 PETECHIAE 36 0.0034
678 PRODUCT DISTRIBUTION ISSUE 32 0.0034
679 BLOOD PRESSURE DECREASED 229 0.0034
680 CEREBRAL INFARCTION 84 0.0034
681 ASTHMA 386 0.0034
682 HICCUPS 28 0.0034
683 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 178 0.0034
684 BLINDNESS UNILATERAL 48 0.0034
685 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 242 0.0034
686 ORAL PAIN 76 0.0034
687 BLINDNESS TRANSIENT 25 0.0034
688 INCORRECT ROUTE OF DRUG ADMINISTRATION 121 0.0034
689 BRAIN NEOPLASM 31 0.0034
690 ALANINE AMINOTRANSFERASE INCREASED 207 0.0034
691 NEPHROTIC SYNDROME 23 0.0034
692 HAEMORRHAGIC STROKE 26 0.0033
693 SKIN ULCER 86 0.0033
694 LIP DRY 30 0.0033
695 SPEECH DISORDER 173 0.0033
696 LIVER DISORDER 146 0.0033
697 DEPRESSED MOOD 172 0.0033
698 GASTROINTESTINAL INFECTION 29 0.0032
699 ANGIOEDEMA 143 0.0032
700 CARDIAC FAILURE 259 0.0032
701 PULMONARY MASS 48 0.0032
702 RESPIRATORY SYNCYTIAL VIRUS INFECTION 28 0.0032
703 FUNGAL INFECTION 107 0.0032
704 FEEDING DISORDER 65 0.0032
705 IMPAIRED QUALITY OF LIFE 46 0.0032
706 ABNORMAL DREAMS 88 0.0032
707 CONSTIPATION 695 0.0032
708 PANIC REACTION 23 0.0032
709 ECZEMA 166 0.0032
710 BLOOD UREA INCREASED 53 0.0032
711 RHABDOMYOLYSIS 132 0.0032
712 THERAPY CHANGE 31 0.0031
713 RENAL CYST 25 0.0031
714 OSTEOARTHRITIS 133 0.0031
715 NOCTURIA 38 0.0031
716 LOWER RESPIRATORY TRACT INFECTION 142 0.0031
717 DIPLOPIA 81 0.0031
718 BLOOD IRON DECREASED 37 0.0031
719 APHASIA 94 0.0031
720 FOOT FRACTURE 59 0.0031
721 EYE IRRITATION 179 0.0031
722 ABDOMINAL PAIN 720 0.0031
723 HIATUS HERNIA 40 0.0031
724 FLUSHING 314 0.0031
725 PHOTOSENSITIVITY REACTION 51 0.0031
726 SYNCOPE 308 0.0031
727 HEART RATE DECREASED 108 0.0031
728 LEUKAEMIA 29 0.0031
729 FOOT DEFORMITY 34 0.0031
730 NODULE 40 0.0031
731 ASPHYXIA 25 0.0031
732 PRODUCT USE ISSUE 575 0.0031
733 JOINT RANGE OF MOTION DECREASED 41 0.0031
734 SENSORY DISTURBANCE 49 0.0031
735 HYPERTHYROIDISM 44 0.0030
736 TRICUSPID VALVE INCOMPETENCE 24 0.0030
737 EYE INFECTION 34 0.0030
738 EXPIRED PRODUCT ADMINISTERED 100 0.0030
739 PNEUMONIA 974 0.0030
740 ABDOMINAL PAIN LOWER 76 0.0030
741 PROCEDURAL COMPLICATION 23 0.0030
742 GENERALISED OEDEMA 37 0.0030
743 THROMBOSIS 240 0.0030
744 NIGHTMARE 103 0.0030
745 PRODUCT ODOUR ABNORMAL 31 0.0030
746 PROCEDURAL PAIN 82 0.0030
747 RETCHING 63 0.0030
748 RETINAL DETACHMENT 27 0.0029
749 WOUND 82 0.0029
750 ASPARTATE AMINOTRANSFERASE INCREASED 155 0.0029
751 ANXIETY 830 0.0029
752 LYMPHOMA 45 0.0029
753 DECREASED APPETITE 670 0.0029
754 EMPHYSEMA 29 0.0029
755 LACERATION 27 0.0029
756 URINARY INCONTINENCE 85 0.0029
757 SKIN EXFOLIATION 240 0.0028
758 ANOSMIA 41 0.0028
759 INITIAL INSOMNIA 29 0.0028
760 CELLULITIS 142 0.0028
761 DERMATITIS 59 0.0028
762 AGEUSIA 70 0.0028
763 SCAR 48 0.0028
764 COVID-19 PNEUMONIA 33 0.0028
765 ERYTHEMA MULTIFORME 26 0.0028
766 HYPERTENSIVE CRISIS 31 0.0028
767 DECREASED ACTIVITY 30 0.0028
768 OCULAR HYPERAEMIA 131 0.0028
769 PRODUCT DOSE OMISSION IN ERROR 78 0.0028
770 PULMONARY THROMBOSIS 30 0.0027
771 PRODUCT PACKAGING ISSUE 26 0.0027
772 DISORIENTATION 108 0.0027
773 NERVOUS SYSTEM DISORDER 85 0.0027
774 RIB FRACTURE 56 0.0027
775 SUPRAVENTRICULAR TACHYCARDIA 26 0.0027
776 SALIVARY HYPERSECRETION 27 0.0027
777 CARDIAC FAILURE CONGESTIVE 215 0.0027
778 BLOOD POTASSIUM DECREASED 80 0.0027
779 DEPRESSION 603 0.0026
780 PYREXIA 917 0.0026
781 RENAL IMPAIRMENT 221 0.0026
782 CYST 32 0.0026
783 HYPOTHYROIDISM 82 0.0026
784 DIARRHOEA HAEMORRHAGIC 24 0.0026
785 LOSS OF CONSCIOUSNESS 328 0.0026
786 COLON CANCER 38 0.0025
787 ABASIA 63 0.0025
788 BACTERIAL INFECTION 47 0.0025
789 POST PROCEDURAL HAEMORRHAGE 29 0.0025
790 DIABETES MELLITUS INADEQUATE CONTROL 44 0.0025
791 OSTEOPOROSIS 102 0.0025
792 LUNG DISORDER 121 0.0025
793 APATHY 36 0.0025
794 DEHYDRATION 329 0.0025
795 IRRITABILITY 148 0.0025
796 INCONTINENCE 26 0.0025
797 GLOSSODYNIA 55 0.0025
798 CONDITION AGGRAVATED 746 0.0025
799 ORAL CANDIDIASIS 32 0.0024
800 POLYNEUROPATHY 29 0.0024
801 ORTHOSTATIC HYPOTENSION 42 0.0024
802 DEVICE DELIVERY SYSTEM ISSUE 66 0.0024
803 SKIN INFECTION 27 0.0024
804 SKIN LESION 66 0.0024
805 BLOOD CREATININE INCREASED 156 0.0024
806 HYPERGLYCAEMIA 87 0.0024
807 LUNG NEOPLASM MALIGNANT 98 0.0024
808 RED BLOOD CELL SEDIMENTATION RATE INCREASED 26 0.0023
809 ANAPHYLACTIC REACTION 129 0.0023
810 ULCER 37 0.0023
811 OBESITY 37 0.0023
812 BODY TEMPERATURE INCREASED 47 0.0023
813 DRY SKIN 304 0.0023
814 INTRAOCULAR PRESSURE INCREASED 29 0.0023
815 INCORRECT PRODUCT ADMINISTRATION DURATION 49 0.0023
816 EATING DISORDER 48 0.0023
817 VOMITING 1057 0.0022
818 ISCHAEMIC STROKE 40 0.0022
819 VENTRICULAR TACHYCARDIA 37 0.0022
820 PHOTOPHOBIA 42 0.0022
821 SKIN CANCER 48 0.0022
822 BLOOD SODIUM DECREASED 42 0.0022
823 IMMUNODEFICIENCY 33 0.0022
824 MOVEMENT DISORDER 71 0.0022
825 GINGIVAL BLEEDING 30 0.0022
826 DEVICE DEPLOYMENT ISSUE 28 0.0022
827 JOINT DISLOCATION 23 0.0022
828 SUDDEN DEATH 23 0.0022
829 FRACTURE 41 0.0022
830 IMPAIRED HEALING 71 0.0022
831 PRODUCT USE COMPLAINT 34 0.0022
832 DEVICE LEAKAGE 93 0.0021
833 DEATH 1843 0.0021
834 HEPATIC CIRRHOSIS 40 0.0021
835 HYPOPHAGIA 54 0.0021
836 SOMNOLENCE 425 0.0021
837 SKIN FISSURES 41 0.0021
838 COMPLICATION ASSOCIATED WITH DEVICE 30 0.0021
839 STAPHYLOCOCCAL INFECTION 68 0.0021
840 ANAPHYLACTIC SHOCK 53 0.0021
841 PANCREATITIS ACUTE 46 0.0020
842 TRANSAMINASES INCREASED 45 0.0020
843 MUSCLE RIGIDITY 24 0.0020
844 MENTAL DISORDER 87 0.0020
845 HYPOTENSION 401 0.0020
846 LIVER INJURY 49 0.0020
847 MOOD ALTERED 54 0.0020
848 OEDEMA 107 0.0020
849 DYSARTHRIA 74 0.0020
850 DRUG EFFECT DECREASED 105 0.0019
851 HAEMORRHOIDS 38 0.0019
852 CONJUNCTIVITIS 36 0.0019
853 RESTLESSNESS 71 0.0019
854 ATAXIA 23 0.0019
855 RHEUMATOID ARTHRITIS 220 0.0019
856 FEAR 52 0.0019
857 COLITIS 73 0.0019
858 THERAPY PARTIAL RESPONDER 30 0.0019
859 CHRONIC KIDNEY DISEASE 146 0.0019
860 PANIC ATTACK 70 0.0019
861 CANDIDA INFECTION 32 0.0019
862 GASTRIC ULCER 36 0.0019
863 LIVER FUNCTION TEST ABNORMAL 55 0.0019
864 SYSTEMIC LUPUS ERYTHEMATOSUS 67 0.0019
865 OEDEMA PERIPHERAL 230 0.0019
866 PRODUCT PRESCRIBING ISSUE 41 0.0019
867 PULMONARY FIBROSIS 36 0.0019
868 HAIR TEXTURE ABNORMAL 25 0.0019
869 HAEMORRHAGE 195 0.0019
870 PERICARDIAL EFFUSION 43 0.0019
871 PLATELET COUNT INCREASED 24 0.0018
872 HAEMATURIA 63 0.0018
873 PRODUCT PHYSICAL ISSUE 37 0.0018
874 URINARY RETENTION 61 0.0018
875 PAIN OF SKIN 49 0.0018
876 LUNG INFECTION 28 0.0018
877 STOMATITIS 109 0.0018
878 MALIGNANT MELANOMA 24 0.0018
879 CEREBRAL HAEMORRHAGE 64 0.0018
880 HAEMOPTYSIS 49 0.0018
881 INFECTION 254 0.0018
882 DRUG-INDUCED LIVER INJURY 55 0.0018
883 HYPOGLYCAEMIA 85 0.0018
884 INTESTINAL OBSTRUCTION 65 0.0017
885 HEPATIC FUNCTION ABNORMAL 64 0.0017
886 PSORIATIC ARTHROPATHY 69 0.0017
887 SEPSIS 189 0.0017
888 HEPATITIS 43 0.0017
889 PULMONARY OEDEMA 75 0.0017
890 HAEMATOCHEZIA 92 0.0017
891 BASAL CELL CARCINOMA 26 0.0017
892 TACHYCARDIA 147 0.0017
893 SKIN BURNING SENSATION 116 0.0016
894 CARDIOGENIC SHOCK 23 0.0016
895 APPLICATION SITE ERYTHEMA 42 0.0016
896 CARDIAC ARREST 132 0.0016
897 RENAL FAILURE 210 0.0016
898 MOUTH ULCERATION 33 0.0016
899 ACTIVITIES OF DAILY LIVING IMPAIRED 31 0.0016
900 WHITE BLOOD CELL COUNT INCREASED 60 0.0016
901 RESPIRATORY DISTRESS 43 0.0016
902 BREAST CANCER 144 0.0015
903 PELVIC PAIN 28 0.0015
904 RECTAL HAEMORRHAGE 66 0.0015
905 HEMIPARESIS 26 0.0015
906 EMOTIONAL DISORDER 47 0.0015
907 DRUG ERUPTION 27 0.0015
908 TREATMENT NONCOMPLIANCE 83 0.0015
909 DRUG INEFFECTIVE 1920 0.0015
910 C-REACTIVE PROTEIN INCREASED 53 0.0015
911 COAGULOPATHY 24 0.0014
912 ACNE 109 0.0014
913 SEIZURE 165 0.0014
914 PERICARDITIS 24 0.0014
915 OXYGEN SATURATION DECREASED 80 0.0014
916 FEMUR FRACTURE 44 0.0014
917 CLOSTRIDIUM DIFFICILE INFECTION 31 0.0014
918 PROSTATE CANCER 114 0.0014
919 BLOOD BILIRUBIN INCREASED 38 0.0014
920 DRUG PRESCRIBING ERROR 27 0.0014
921 RED BLOOD CELL COUNT DECREASED 40 0.0014
922 GAMMA-GLUTAMYLTRANSFERASE INCREASED 31 0.0014
923 ANGER 47 0.0014
924 OSTEOMYELITIS 25 0.0014
925 PLEURAL EFFUSION 84 0.0014
926 DYSKINESIA 56 0.0014
927 PROTEINURIA 26 0.0014
928 PALLOR 36 0.0013
929 PSORIASIS 172 0.0013
930 SKIN IRRITATION 59 0.0013
931 MOOD SWINGS 41 0.0013
932 PANCREATIC CARCINOMA 37 0.0013
933 THERAPEUTIC RESPONSE SHORTENED 42 0.0013
934 CONTRAINDICATED PRODUCT ADMINISTERED 38 0.0013
935 AGITATION 92 0.0013
936 HALLUCINATION 93 0.0012
937 PRODUCT AVAILABILITY ISSUE 27 0.0012
938 CRYING 43 0.0012
939 PULMONARY EMBOLISM 111 0.0012
940 BLOOD ALKALINE PHOSPHATASE INCREASED 29 0.0012
941 INTERNATIONAL NORMALISED RATIO INCREASED 32 0.0011
942 COLITIS ULCERATIVE 50 0.0011
943 ANAEMIA 212 0.0011
944 BRADYCARDIA 58 0.0011
945 DEEP VEIN THROMBOSIS 70 0.0011
946 GENERAL PHYSICAL HEALTH DETERIORATION 123 0.0011
947 HAEMOGLOBIN DECREASED 109 0.0011
948 RESPIRATORY ARREST 29 0.0011
949 MENTAL STATUS CHANGES 29 0.0010
950 INTENTIONAL PRODUCT USE ISSUE 91 0.0010
951 INJURY 73 0.0010
952 ACCIDENTAL OVERDOSE 37 0.0010
953 GASTROINTESTINAL HAEMORRHAGE 84 0.0010
954 JAUNDICE 27 0.0010
955 BLADDER CANCER 57 0.0010
956 DISEASE RECURRENCE 46 0.0010
957 ACUTE KIDNEY INJURY 144 0.0009
958 BREAST CANCER FEMALE 25 0.0009
959 PNEUMONIA ASPIRATION 23 0.0009
960 EPILEPSY 28 0.0009
961 DERMATITIS ATOPIC 48 0.0009
962 CARDIO-RESPIRATORY ARREST 38 0.0009
963 HYPOXIA 32 0.0009
964 PRODUCT USE IN UNAPPROVED INDICATION 225 0.0009
965 SUICIDAL IDEATION 83 0.0009
966 DRUG RESISTANCE 23 0.0009
967 DRUG INTERACTION 133 0.0008
968 MULTIPLE SCLEROSIS 39 0.0008
969 DEVICE BREAKAGE 33 0.0008
970 HEPATIC FAILURE 24 0.0008
971 PLASMA CELL MYELOMA 31 0.0008
972 PLATELET COUNT DECREASED 83 0.0008
973 INTERSTITIAL LUNG DISEASE 37 0.0008
974 DISEASE PROGRESSION 90 0.0008
975 DELIRIUM 26 0.0007
976 HYPOKALAEMIA 33 0.0007
977 HYPERKALAEMIA 25 0.0007
978 PRODUCT QUALITY ISSUE 95 0.0007
979 WHITE BLOOD CELL COUNT DECREASED 74 0.0007
980 VAGINAL HAEMORRHAGE 29 0.0007
981 THROMBOCYTOPENIA 71 0.0006
982 PRODUCT SUBSTITUTION ISSUE 35 0.0006
983 RESPIRATORY FAILURE 41 0.0006
984 HYPONATRAEMIA 31 0.0005
985 AGGRESSION 24 0.0005
986 TREATMENT FAILURE 38 0.0005
987 EMOTIONAL DISTRESS 51 0.0004
988 MATERNAL EXPOSURE DURING PREGNANCY 37 0.0004
989 PANCYTOPENIA 23 0.0004
990 NO ADVERSE EVENT 62 0.0003
991 OVERDOSE 54 0.0003